Skip to main content
Fig. 4 | BMC Cardiovascular Disorders

Fig. 4

From: Salvianolic acid a inhibits platelet activation and aggregation in patients with type 2 diabetes mellitus

Fig. 4

Representative histograms of the expression level of the active form of PAC-1 on non-stimulated platelets (shown as Rest) (a) and on platelets stimulated with ADP (b, c) or thrombin (d, e) in PRP, preincubated with a vehicle (b, d) or SAA (c, e) (0.1 mg/ml; 22 °C; 10 min). For each sample, 5000 platelets were acquired. The platelets were labeled with the monoclonal antibody, anti-PAC-1 (FITC)

Back to article page